DAVENPORT FRED B JR
SEC Form 4 insider trading activity
DAVENPORT FRED B JR has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Aug 21, 2026.
On the most recent filing, DAVENPORT FRED B JR is listed as Director at Medpace Holdings, Inc. Inside the rolling window, DAVENPORT FRED B JR reported no open-market purchases and 1 open-market sale totaling $4.4M in MEDP.
Companies traded
Other insiders at MEDP
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 30, 2025 | MEDP | Sale | $3.5M |
Frequently asked questions
How many SEC Form 4 filings has DAVENPORT FRED B JR made?
DAVENPORT FRED B JR has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does DAVENPORT FRED B JR trade?
DAVENPORT FRED B JR has filed SEC Form 4 disclosures for 1 company, including MEDP.
When was DAVENPORT FRED B JR's most recent SEC Form 4 filing?
DAVENPORT FRED B JR's most recent SEC Form 4 filing on Tracefour is dated Aug 21, 2026.
What is DAVENPORT FRED B JR's total buy and sell value in the current window?
Inside the rolling retention window, DAVENPORT FRED B JR bought $0 and sold $4.4M based on SEC Form 4 filings.
What was DAVENPORT FRED B JR's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 7,283 MEDP shares on 2026-08-19, worth $4.4M, per SEC Form 4 filings.